Shardul Amarchand Mangaldas & Co. advised ChrysCapital and Client Associates Alternate Fund on their secondary investment in Bright Lifecare Private Limited (HealthKart), valued at approximately USD 153 million. The firm also assisted HealthKart during this investment round, which included participation from Motilal Oswal Alternates. The deal aims to enhance HealthKart’s operations in India’s burgeoning healthcare sector. The transaction teams for both parties comprised several partners and associates, with Avendus Capital serving as the exclusive financial advisor for HealthKart and its shareholders, while EY India provided financial and tax advisory services to ChrysCapital.